0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biotechnology and Pharmaceutical Gases Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-28E16773
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biotechnology and Pharmaceutical Gases Market Research Report 2024
BUY CHAPTERS

Global Biotechnology and Pharmaceutical Gases Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-28E16773
Report
November 2025
Pages:169
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biotechnology and Pharmaceutical Gases Market

The global Biotechnology and Pharmaceutical Gases market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Laboratory accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Biotechnology and Pharmaceutical Gases leading manufacturers including Air Liquide, Linde, Air Products, Taiyo Nippon Sanso, Matheson, Messer Group, SOL Group, Coregas, INOX Air Products, HangYang, etc., dominate supply; the top five capture approximately % of global revenue, with Air Liquide leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Biotechnology and Pharmaceutical Gases market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Biotechnology and Pharmaceutical Gases Market Report

Report Metric Details
Report Name Biotechnology and Pharmaceutical Gases Market
Segment by Type
  • Carbon Dioxide
  • Nitrogen
  • Oxygen
  • Others
Segment by Application
  • Laboratory
  • Pharmaceutical and Biotechnology Companies
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Air Liquide, Linde, Air Products, Taiyo Nippon Sanso, Matheson, Messer Group, SOL Group, Coregas, INOX Air Products, HangYang, Shenzhen Gaofa Gas
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Biotechnology and Pharmaceutical Gases study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Biotechnology and Pharmaceutical Gases Market report?

Ans: The main players in the Biotechnology and Pharmaceutical Gases Market are Air Liquide, Linde, Air Products, Taiyo Nippon Sanso, Matheson, Messer Group, SOL Group, Coregas, INOX Air Products, HangYang, Shenzhen Gaofa Gas

What are the Application segmentation covered in the Biotechnology and Pharmaceutical Gases Market report?

Ans: The Applications covered in the Biotechnology and Pharmaceutical Gases Market report are Laboratory, Pharmaceutical and Biotechnology Companies, Others

What are the Type segmentation covered in the Biotechnology and Pharmaceutical Gases Market report?

Ans: The Types covered in the Biotechnology and Pharmaceutical Gases Market report are Carbon Dioxide, Nitrogen, Oxygen, Others

1 Study Coverage
1.1 Introduction to Biotechnology and Pharmaceutical Gases: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Biotechnology and Pharmaceutical Gases Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Carbon Dioxide
1.2.3 Nitrogen
1.2.4 Oxygen
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Biotechnology and Pharmaceutical Gases Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Laboratory
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biotechnology and Pharmaceutical Gases Revenue Estimates and Forecasts 2020-2031
2.2 Global Biotechnology and Pharmaceutical Gases Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Biotechnology and Pharmaceutical Gases Sales Estimates and Forecasts 2020-2031
2.4 Global Biotechnology and Pharmaceutical Gases Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Biotechnology and Pharmaceutical Gases Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Biotechnology and Pharmaceutical Gases Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Biotechnology and Pharmaceutical Gases Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Carbon Dioxide Market Size by Manufacturers
4.5.2 Nitrogen Market Size by Manufacturers
4.5.3 Oxygen Market Size by Manufacturers
4.5.4 Others Market Size by Manufacturers
4.6 Global Biotechnology and Pharmaceutical Gases Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Biotechnology and Pharmaceutical Gases Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Biotechnology and Pharmaceutical Gases Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Biotechnology and Pharmaceutical Gases Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Biotechnology and Pharmaceutical Gases Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Biotechnology and Pharmaceutical Gases Sales and Revenue by Type (2020-2031)
7.4 North America Biotechnology and Pharmaceutical Gases Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Biotechnology and Pharmaceutical Gases Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Biotechnology and Pharmaceutical Gases Sales and Revenue by Type (2020-2031)
8.4 Europe Biotechnology and Pharmaceutical Gases Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Biotechnology and Pharmaceutical Gases Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Biotechnology and Pharmaceutical Gases Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Biotechnology and Pharmaceutical Gases Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Biotechnology and Pharmaceutical Gases Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Biotechnology and Pharmaceutical Gases Sales and Revenue by Type (2020-2031)
10.4 Central and South America Biotechnology and Pharmaceutical Gases Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Biotechnology and Pharmaceutical Gases Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Biotechnology and Pharmaceutical Gases Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Biotechnology and Pharmaceutical Gases Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Biotechnology and Pharmaceutical Gases Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Air Liquide
12.1.1 Air Liquide Corporation Information
12.1.2 Air Liquide Business Overview
12.1.3 Air Liquide Biotechnology and Pharmaceutical Gases Product Models, Descriptions and Specifications
12.1.4 Air Liquide Biotechnology and Pharmaceutical Gases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Air Liquide Biotechnology and Pharmaceutical Gases Sales by Product in 2024
12.1.6 Air Liquide Biotechnology and Pharmaceutical Gases Sales by Application in 2024
12.1.7 Air Liquide Biotechnology and Pharmaceutical Gases Sales by Geographic Area in 2024
12.1.8 Air Liquide Biotechnology and Pharmaceutical Gases SWOT Analysis
12.1.9 Air Liquide Recent Developments
12.2 Linde
12.2.1 Linde Corporation Information
12.2.2 Linde Business Overview
12.2.3 Linde Biotechnology and Pharmaceutical Gases Product Models, Descriptions and Specifications
12.2.4 Linde Biotechnology and Pharmaceutical Gases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Linde Biotechnology and Pharmaceutical Gases Sales by Product in 2024
12.2.6 Linde Biotechnology and Pharmaceutical Gases Sales by Application in 2024
12.2.7 Linde Biotechnology and Pharmaceutical Gases Sales by Geographic Area in 2024
12.2.8 Linde Biotechnology and Pharmaceutical Gases SWOT Analysis
12.2.9 Linde Recent Developments
12.3 Air Products
12.3.1 Air Products Corporation Information
12.3.2 Air Products Business Overview
12.3.3 Air Products Biotechnology and Pharmaceutical Gases Product Models, Descriptions and Specifications
12.3.4 Air Products Biotechnology and Pharmaceutical Gases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Air Products Biotechnology and Pharmaceutical Gases Sales by Product in 2024
12.3.6 Air Products Biotechnology and Pharmaceutical Gases Sales by Application in 2024
12.3.7 Air Products Biotechnology and Pharmaceutical Gases Sales by Geographic Area in 2024
12.3.8 Air Products Biotechnology and Pharmaceutical Gases SWOT Analysis
12.3.9 Air Products Recent Developments
12.4 Taiyo Nippon Sanso
12.4.1 Taiyo Nippon Sanso Corporation Information
12.4.2 Taiyo Nippon Sanso Business Overview
12.4.3 Taiyo Nippon Sanso Biotechnology and Pharmaceutical Gases Product Models, Descriptions and Specifications
12.4.4 Taiyo Nippon Sanso Biotechnology and Pharmaceutical Gases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Taiyo Nippon Sanso Biotechnology and Pharmaceutical Gases Sales by Product in 2024
12.4.6 Taiyo Nippon Sanso Biotechnology and Pharmaceutical Gases Sales by Application in 2024
12.4.7 Taiyo Nippon Sanso Biotechnology and Pharmaceutical Gases Sales by Geographic Area in 2024
12.4.8 Taiyo Nippon Sanso Biotechnology and Pharmaceutical Gases SWOT Analysis
12.4.9 Taiyo Nippon Sanso Recent Developments
12.5 Matheson
12.5.1 Matheson Corporation Information
12.5.2 Matheson Business Overview
12.5.3 Matheson Biotechnology and Pharmaceutical Gases Product Models, Descriptions and Specifications
12.5.4 Matheson Biotechnology and Pharmaceutical Gases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Matheson Biotechnology and Pharmaceutical Gases Sales by Product in 2024
12.5.6 Matheson Biotechnology and Pharmaceutical Gases Sales by Application in 2024
12.5.7 Matheson Biotechnology and Pharmaceutical Gases Sales by Geographic Area in 2024
12.5.8 Matheson Biotechnology and Pharmaceutical Gases SWOT Analysis
12.5.9 Matheson Recent Developments
12.6 Messer Group
12.6.1 Messer Group Corporation Information
12.6.2 Messer Group Business Overview
12.6.3 Messer Group Biotechnology and Pharmaceutical Gases Product Models, Descriptions and Specifications
12.6.4 Messer Group Biotechnology and Pharmaceutical Gases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Messer Group Recent Developments
12.7 SOL Group
12.7.1 SOL Group Corporation Information
12.7.2 SOL Group Business Overview
12.7.3 SOL Group Biotechnology and Pharmaceutical Gases Product Models, Descriptions and Specifications
12.7.4 SOL Group Biotechnology and Pharmaceutical Gases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 SOL Group Recent Developments
12.8 Coregas
12.8.1 Coregas Corporation Information
12.8.2 Coregas Business Overview
12.8.3 Coregas Biotechnology and Pharmaceutical Gases Product Models, Descriptions and Specifications
12.8.4 Coregas Biotechnology and Pharmaceutical Gases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Coregas Recent Developments
12.9 INOX Air Products
12.9.1 INOX Air Products Corporation Information
12.9.2 INOX Air Products Business Overview
12.9.3 INOX Air Products Biotechnology and Pharmaceutical Gases Product Models, Descriptions and Specifications
12.9.4 INOX Air Products Biotechnology and Pharmaceutical Gases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 INOX Air Products Recent Developments
12.10 HangYang
12.10.1 HangYang Corporation Information
12.10.2 HangYang Business Overview
12.10.3 HangYang Biotechnology and Pharmaceutical Gases Product Models, Descriptions and Specifications
12.10.4 HangYang Biotechnology and Pharmaceutical Gases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 HangYang Recent Developments
12.11 Shenzhen Gaofa Gas
12.11.1 Shenzhen Gaofa Gas Corporation Information
12.11.2 Shenzhen Gaofa Gas Business Overview
12.11.3 Shenzhen Gaofa Gas Biotechnology and Pharmaceutical Gases Product Models, Descriptions and Specifications
12.11.4 Shenzhen Gaofa Gas Biotechnology and Pharmaceutical Gases Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Shenzhen Gaofa Gas Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Biotechnology and Pharmaceutical Gases Industry Chain
13.2 Biotechnology and Pharmaceutical Gases Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Biotechnology and Pharmaceutical Gases Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Biotechnology and Pharmaceutical Gases Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Biotechnology and Pharmaceutical Gases Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Biotechnology and Pharmaceutical Gases Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
 Table 1. Global Biotechnology and Pharmaceutical Gases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Biotechnology and Pharmaceutical Gases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Biotechnology and Pharmaceutical Gases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Biotechnology and Pharmaceutical Gases Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Biotechnology and Pharmaceutical Gases Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Biotechnology and Pharmaceutical Gases Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)
 Table 7. Global Biotechnology and Pharmaceutical Gases Sales by Region (2020-2025) & (Kilotons)
 Table 8. Global Biotechnology and Pharmaceutical Gases Sales by Region (2026-2031) & (Kilotons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Biotechnology and Pharmaceutical Gases Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)
 Table 11. Global Biotechnology and Pharmaceutical Gases Production by Region (2020-2025) & (Kilotons)
 Table 12. Global Biotechnology and Pharmaceutical Gases Production by Region (2026-2031) & (Kilotons)
 Table 13. Global Biotechnology and Pharmaceutical Gases Sales by Manufacturers (2020-2025) & (Kilotons)
 Table 14. Global Biotechnology and Pharmaceutical Gases Sales Share by Manufacturers (2020-2025)
 Table 15. Global Biotechnology and Pharmaceutical Gases Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Biotechnology and Pharmaceutical Gases Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Biotechnology and Pharmaceutical Gases by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotechnology and Pharmaceutical Gases as of 2024)
 Table 19. Global Biotechnology and Pharmaceutical Gases Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Biotechnology and Pharmaceutical Gases Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Biotechnology and Pharmaceutical Gases Manufacturing Base and Headquarters
 Table 22. Global Biotechnology and Pharmaceutical Gases Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Biotechnology and Pharmaceutical Gases Sales by Type (2020-2025) & (Kilotons)
 Table 26. Global Biotechnology and Pharmaceutical Gases Sales by Type (2026-2031) & (Kilotons)
 Table 27. Global Biotechnology and Pharmaceutical Gases Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Biotechnology and Pharmaceutical Gases Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Biotechnology and Pharmaceutical Gases ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Biotechnology and Pharmaceutical Gases Sales by Application (2020-2025) & (Kilotons)
 Table 32. Global Biotechnology and Pharmaceutical Gases Sales by Application (2026-2031) & (Kilotons)
 Table 33. Biotechnology and Pharmaceutical Gases High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Biotechnology and Pharmaceutical Gases Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Biotechnology and Pharmaceutical Gases Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Biotechnology and Pharmaceutical Gases ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Biotechnology and Pharmaceutical Gases Growth Accelerators and Market Barriers
 Table 40. North America Biotechnology and Pharmaceutical Gases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Biotechnology and Pharmaceutical Gases Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Biotechnology and Pharmaceutical Gases Growth Accelerators and Market Barriers
 Table 43. Europe Biotechnology and Pharmaceutical Gases Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Biotechnology and Pharmaceutical Gases Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Biotechnology and Pharmaceutical Gases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Biotechnology and Pharmaceutical Gases Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Biotechnology and Pharmaceutical Gases Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Biotechnology and Pharmaceutical Gases Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Biotechnology and Pharmaceutical Gases Investment Opportunities and Key Challenges
 Table 50. Central and South America Biotechnology and Pharmaceutical Gases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Biotechnology and Pharmaceutical Gases Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Biotechnology and Pharmaceutical Gases Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Air Liquide Corporation Information
 Table 54. Air Liquide Description and Major Businesses
 Table 55. Air Liquide Product Models, Descriptions and Specifications
 Table 56. Air Liquide Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Air Liquide Sales Value Proportion by Product in 2024
 Table 58. Air Liquide Sales Value Proportion by Application in 2024
 Table 59. Air Liquide Sales Value Proportion by Geographic Area in 2024
 Table 60. Air Liquide Biotechnology and Pharmaceutical Gases SWOT Analysis
 Table 61. Air Liquide Recent Developments
 Table 62. Linde Corporation Information
 Table 63. Linde Description and Major Businesses
 Table 64. Linde Product Models, Descriptions and Specifications
 Table 65. Linde Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Linde Sales Value Proportion by Product in 2024
 Table 67. Linde Sales Value Proportion by Application in 2024
 Table 68. Linde Sales Value Proportion by Geographic Area in 2024
 Table 69. Linde Biotechnology and Pharmaceutical Gases SWOT Analysis
 Table 70. Linde Recent Developments
 Table 71. Air Products Corporation Information
 Table 72. Air Products Description and Major Businesses
 Table 73. Air Products Product Models, Descriptions and Specifications
 Table 74. Air Products Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Air Products Sales Value Proportion by Product in 2024
 Table 76. Air Products Sales Value Proportion by Application in 2024
 Table 77. Air Products Sales Value Proportion by Geographic Area in 2024
 Table 78. Air Products Biotechnology and Pharmaceutical Gases SWOT Analysis
 Table 79. Air Products Recent Developments
 Table 80. Taiyo Nippon Sanso Corporation Information
 Table 81. Taiyo Nippon Sanso Description and Major Businesses
 Table 82. Taiyo Nippon Sanso Product Models, Descriptions and Specifications
 Table 83. Taiyo Nippon Sanso Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Taiyo Nippon Sanso Sales Value Proportion by Product in 2024
 Table 85. Taiyo Nippon Sanso Sales Value Proportion by Application in 2024
 Table 86. Taiyo Nippon Sanso Sales Value Proportion by Geographic Area in 2024
 Table 87. Taiyo Nippon Sanso Biotechnology and Pharmaceutical Gases SWOT Analysis
 Table 88. Taiyo Nippon Sanso Recent Developments
 Table 89. Matheson Corporation Information
 Table 90. Matheson Description and Major Businesses
 Table 91. Matheson Product Models, Descriptions and Specifications
 Table 92. Matheson Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Matheson Sales Value Proportion by Product in 2024
 Table 94. Matheson Sales Value Proportion by Application in 2024
 Table 95. Matheson Sales Value Proportion by Geographic Area in 2024
 Table 96. Matheson Biotechnology and Pharmaceutical Gases SWOT Analysis
 Table 97. Matheson Recent Developments
 Table 98. Messer Group Corporation Information
 Table 99. Messer Group Description and Major Businesses
 Table 100. Messer Group Product Models, Descriptions and Specifications
 Table 101. Messer Group Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. Messer Group Recent Developments
 Table 103. SOL Group Corporation Information
 Table 104. SOL Group Description and Major Businesses
 Table 105. SOL Group Product Models, Descriptions and Specifications
 Table 106. SOL Group Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. SOL Group Recent Developments
 Table 108. Coregas Corporation Information
 Table 109. Coregas Description and Major Businesses
 Table 110. Coregas Product Models, Descriptions and Specifications
 Table 111. Coregas Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 112. Coregas Recent Developments
 Table 113. INOX Air Products Corporation Information
 Table 114. INOX Air Products Description and Major Businesses
 Table 115. INOX Air Products Product Models, Descriptions and Specifications
 Table 116. INOX Air Products Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 117. INOX Air Products Recent Developments
 Table 118. HangYang Corporation Information
 Table 119. HangYang Description and Major Businesses
 Table 120. HangYang Product Models, Descriptions and Specifications
 Table 121. HangYang Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 122. HangYang Recent Developments
 Table 123. Shenzhen Gaofa Gas Corporation Information
 Table 124. Shenzhen Gaofa Gas Description and Major Businesses
 Table 125. Shenzhen Gaofa Gas Product Models, Descriptions and Specifications
 Table 126. Shenzhen Gaofa Gas Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 127. Shenzhen Gaofa Gas Recent Developments
 Table 128. Key Raw Materials Distribution
 Table 129. Raw Materials Key Suppliers
 Table 130. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 131. Milestones in Production Technology Evolution
 Table 132. Distributors List
 Table 133. Market Trends and Market Evolution
 Table 134. Market Drivers and Opportunities
 Table 135. Market Challenges, Risks, and Restraints
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources


List of Figures
 Figure 1. Biotechnology and Pharmaceutical Gases Product Picture
 Figure 2. Global Biotechnology and Pharmaceutical Gases Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Carbon Dioxide Product Picture
 Figure 4. Nitrogen Product Picture
 Figure 5. Oxygen Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Biotechnology and Pharmaceutical Gases Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Laboratory
 Figure 9. Pharmaceutical and Biotechnology Companies
 Figure 10. Others
 Figure 11. Biotechnology and Pharmaceutical Gases Report Years Considered
 Figure 12. Global Biotechnology and Pharmaceutical Gases Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Biotechnology and Pharmaceutical Gases Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Biotechnology and Pharmaceutical Gases Revenue Market Share by Region (2020-2031)
 Figure 16. Global Biotechnology and Pharmaceutical Gases Sales (2020-2031) & (Kilotons)
 Figure 17. Global Biotechnology and Pharmaceutical Gases Sales (CAGR) by Region (2020-2031) (Kilotons)
 Figure 18. Global Biotechnology and Pharmaceutical Gases Sales Market Share by Region (2020-2031)
 Figure 19. Global Biotechnology and Pharmaceutical Gases Capacity, Production and Utilization (2020-2031) & (Kilotons)
 Figure 20. Global Biotechnology and Pharmaceutical Gases Production Trend by Region (2020-2031) (Kilotons)
 Figure 21. Global Biotechnology and Pharmaceutical Gases Production Market Share by Region (2020-2031)
 Figure 22. Production Capacity Enablers & Constraints
 Figure 23. Biotechnology and Pharmaceutical Gases Production Growth Rate in North America (2020-2031) & (Kilotons)
 Figure 24. Biotechnology and Pharmaceutical Gases Production Growth Rate in Europe (2020-2031) & (Kilotons)
 Figure 25. Biotechnology and Pharmaceutical Gases Production Growth Rate in China (2020-2031) & (Kilotons)
 Figure 26. Biotechnology and Pharmaceutical Gases Production Growth Rate in Japan (2020-2031) & (Kilotons)
 Figure 27. Top 5 and Top 10 Manufacturers Biotechnology and Pharmaceutical Gases Sales Volume Market Share in 2024
 Figure 28. Global Biotechnology and Pharmaceutical Gases Revenue Market Share Ranking (2024)
 Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 30. Carbon Dioxide Revenue Market Share by Manufacturer in 2024
 Figure 31. Nitrogen Revenue Market Share by Manufacturer in 2024
 Figure 32. Oxygen Revenue Market Share by Manufacturer in 2024
 Figure 33. Others Revenue Market Share by Manufacturer in 2024
 Figure 34. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 35. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 36. Global Biotechnology and Pharmaceutical Gases Sales Market Share by Type (2020-2031)
 Figure 37. Global Biotechnology and Pharmaceutical Gases Revenue Market Share by Type (2020-2031)
 Figure 38. Global Biotechnology and Pharmaceutical Gases Sales Market Share by Application (2020-2031)
 Figure 39. Global Biotechnology and Pharmaceutical Gases Revenue Market Share by Application (2020-2031)
 Figure 40. North America Biotechnology and Pharmaceutical Gases Sales YoY (2020-2031) & (Kilotons)
 Figure 41. North America Biotechnology and Pharmaceutical Gases Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. North America Top 5 Manufacturers Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) in 2024
 Figure 43. North America Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Type (2020- 2031)
 Figure 44. North America Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 45. North America Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Application (2020-2031)
 Figure 46. North America Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 47. US Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
 Figure 48. Canada Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
 Figure 49. Mexico Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
 Figure 50. Europe Biotechnology and Pharmaceutical Gases Sales YoY (2020-2031) & (Kilotons)
 Figure 51. Europe Biotechnology and Pharmaceutical Gases Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Europe Top 5 Manufacturers Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) in 2024
 Figure 53. Europe Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Type (2020-2031)
 Figure 54. Europe Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Europe Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Application (2020-2031)
 Figure 56. Europe Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Germany Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
 Figure 58. France Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
 Figure 59. U.K. Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
 Figure 60. Italy Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
 Figure 61. Russia Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
 Figure 62. Asia-Pacific Biotechnology and Pharmaceutical Gases Sales YoY (2020-2031) & (Kilotons)
 Figure 63. Asia-Pacific Biotechnology and Pharmaceutical Gases Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Asia-Pacific Top 8 Manufacturers Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) in 2024
 Figure 65. Asia-Pacific Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Type (2020- 2031)
 Figure 66. Asia-Pacific Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 67. Asia-Pacific Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Application (2020-2031)
 Figure 68. Asia-Pacific Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Indonesia Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
 Figure 70. Japan Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
 Figure 71. South Korea Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
 Figure 72. China Taiwan Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
 Figure 73. India Biotechnology and Pharmaceutical Gases Revenue (2020-2031) & (US$ Million)
 Figure 74. Central and South America Biotechnology and Pharmaceutical Gases Sales YoY (2020-2031) & (Kilotons)
 Figure 75. Central and South America Biotechnology and Pharmaceutical Gases Revenue YoY (2020-2031) & (US$ Million)
 Figure 76. Central and South America Top 5 Manufacturers Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) in 2024
 Figure 77. Central and South America Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Type (2021-2031)
 Figure 78. Central and South America Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 79. Central and South America Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Application (2020-2031)
 Figure 80. Central and South America Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 81. Brazil Biotechnology and Pharmaceutical Gases Revenue (2020-2025) & (US$ Million)
 Figure 82. Argentina Biotechnology and Pharmaceutical Gases Revenue (2020-2025) & (US$ Million)
 Figure 83. Middle East, and Africa Biotechnology and Pharmaceutical Gases Sales YoY (2020-2031) & (Kilotons)
 Figure 84. Middle East and Africa Biotechnology and Pharmaceutical Gases Revenue YoY (2020-2031) & (US$ Million)
 Figure 85. Middle East and Africa Top 5 Manufacturers Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) in 2024
 Figure 86. Middle East and Africa Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Type (2021-2031)
 Figure 87. South America Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 88. Middle East and Africa Biotechnology and Pharmaceutical Gases Sales Volume (Kilotons) by Application (2020-2031)
 Figure 89. Middle East and Africa Biotechnology and Pharmaceutical Gases Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 90. GCC Countries Biotechnology and Pharmaceutical Gases Revenue (2020-2025) & (US$ Million)
 Figure 91. Turkey Biotechnology and Pharmaceutical Gases Revenue (2020-2025) & (US$ Million)
 Figure 92. Egypt Biotechnology and Pharmaceutical Gases Revenue (2020-2025) & (US$ Million)
 Figure 93. South Africa Biotechnology and Pharmaceutical Gases Revenue (2020-2025) & (US$ Million)
 Figure 94. Biotechnology and Pharmaceutical Gases Industry Chain Mapping
 Figure 95. Regional Biotechnology and Pharmaceutical Gases Manufacturing Base Distribution (%)
 Figure 96. Biotechnology and Pharmaceutical Gases Production Process
 Figure 97. Regional Biotechnology and Pharmaceutical Gases Production Cost Structure
 Figure 98. Channels of Distribution (Direct Vs Distribution)
 Figure 99. Bottom-up and Top-down Approaches for This Report
 Figure 100. Data Triangulation
 Figure 101. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart